Non-hallucinogenic psychedelics: scientists close in on compound

Discovery could accelerate development of easy-to-use treatments for mental health conditions

Researchers have identified a psychedelic that doesn't trigger hallucinations, a key discovery that could allow scientists to accelerate the development of easy-to-use treatments for mental health and neurological conditions.

Researchers are racing to harness the therapeutic potential of psychedelics for poorly treated conditions such as depression and PTSD. While antipsychotics typically work by altering brain chemistry, psychedelics appear to promote neural plasticity, essentially allowing the brain to rewire itself.